Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy

NASuspendedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions
DizzinessNausea
Interventions
DEVICE

Otoband

Participants with AUV will wear the Otoband set at normal power (effective) during vestibular test battery and outcome measurements will be recorded by the investigator during site visit.

DEVICE

Placebo Device

Participants with AUV will wear the placebo device set at low power during vestibular test battery and outcome measurements will be recorded by the investigator during site visit.

Trial Locations (1)

33136

University of Miami Health System, Miami

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Otolith Labs

INDUSTRY

NCT04226976 - Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy | Biotech Hunter | Biotech Hunter